Insulin increases central apolipoprotein E levels as revealed by an improved technique for collection of cerebrospinal fluid from rats

Journal of Neuroscience Methods

Volumn 209, Issue 1, 2012, Pages 106-112

  Liu, Min ^a   Shen, Ling ^a   Begg, Denovan P ^a   D'alessio, David A ^a   Woods, Stephen C ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Apolipoprotein E; Cerebrospinal fluid collection; Cisternum magnum; Insulin

Indexed keywords

APOLIPOPROTEIN E; GLUCOSE; INSULIN;

ANTIDIABETIC ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONTAMINATION; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; LONG EVANS RAT; MALE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; UPREGULATION;

ANIMALS; APOLIPOPROTEINS E; BLOTTING, WESTERN; CEREBROSPINAL FLUID; INSULIN; MALE; RATS; RATS, LONG-EVANS;

EID: 84863199495     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2012.05.034     Document Type: Article

References (39)

1. Barzilai N., Wang J., Massilon D., Vuguin P., Hawkins M., Rossetti L. Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest 1997, 100:3105-3110.
2. Begg D.P., Woods S.C. The central insulin system and energy balance. Handb Exp Pharmacol 2012, 209:111-129.
3. Bouman H.J., van Wimersma Greidanus T.B. A rapid and simple cannulation technique for repeated sampling of cerebrospinal fluid in freely moving rats. Brain Res Bull 1979, 4:575-577.
4. Boyles J.K., Pitas R.E., Wilson E., Mahley R.W., Taylor J.M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 1985, 76:1501-1513.
5. Burns D., London J., Brunswick D.J., Pring M., Garfinkel D., Rabinowitz J.L., et al. Bennett Award Paper. A kinetic analysis of 5-hydroxyindoleacetic acid excretion from rat brain and csf. Biol Psychiatry 1976, 11:125-157.
6. Cassar S.C., Tovcimak A.E., Rustay N.R., Ellis T.A., Hooker B.A., Witte D.G., et al. Comparing levels of biochemical markers in CSF from cannulated and non-cannulated rats. J Neurosci Methods 2010, 192:249-253.
7. Cserr H. Potassium exchange between cerebrospinal fluid, plasma, and brain. Am J Physiol 1965, 209:1219-1226.
8. De la Calle J.L., Paino C.L. A procedure for direct lumbar puncture in rats. Brain Res Bull 2002, 59:245-250.
9. de W.D., Diamant M., Fodor M. Central nervous system effects of the neurohypophyseal hormones and related peptides. Front Neuroendocrinol 1993, 14:251-302.
10. Halonen T., Pitkanen A., Saano V., Riekkinen P.J. Effects of vigabatrin (gamma-vinyl GABA) on neurotransmission-related amino acids and on GABA and benzodiazepine receptor binding in rats. Epilepsia 1991, 32:242-249.
11. Huang Y.L., Saljo A., Suneson A., Hansson H.A. A new approach for multiple sampling of cisternal cerebrospinal fluid in rodents with minimal trauma and inflammation. J Neurosci Methods 1995, 63:13-22.
12. Hurtt A.E., Smith M.O. Effects of iatrogenic blood contamination on results of cerebrospinal fluid analysis in clinically normal dogs and dogs with neurologic disease. J Am Vet Med Assoc 1997, 211:866-867.
13. Jeong S.M., Hahm K.D., Shin J.W., Leem J.G., Lee C., Han S.M. Changes in magnesium concentration in the serum and cerebrospinal fluid of neuropathic rats. Acta Anaesthesiol Scand 2006, 50:211-216.
14. Johnston M., Papaiconomou C. Cerebrospinal fluid transport: a lymphatic perspective. News Physiol Sci 2002, 17:227-230.
15. Koch S., Donarski N., Goetze K., Kreckel M., Stuerenburg H.J., Buhmann C., et al. Characterization of four lipoprotein classes in human cerebrospinal fluid. J Lipid Res 2001, 42:1143-1151.
16. Lai Y.L., Smith P.M., Lamm W.J., Hildebrandt J. Sampling and analysis of cerebrospinal fluid for chronic studies in awake rats. J Appl Physiol 1983, 54:1754-1757.
17. Lindquist L., Linne T., Hansson L.O., Kalin M., Axelsson G. Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection. Eur J Clin Microbiol Infect Dis 1988, 7:374-380.
18. Lo C.M., Nordskog B.K., Nauli A.M., Zheng S., Vonlehmden S.B., Yang Q., et al. Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation?. Am J Physiol Gastrointest Liver Physiol 2008, 294:G344-G352.
19. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630.
20. Meek J.L., Neff N.H. Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain?. Neuropharmacology 1973, 12:497-499.
21. Nirogi R., Kandikere V., Mudigonda K., Bhyrapuneni G., Muddana N., Saralaya R., et al. A simple and rapid method to collect the cerebrospinal fluid of rats and its application for the assessment of drug penetration into the central nervous system. J Neurosci Methods 2009, 178:116-119.
22. Niswender K.D., Morrison C.D., Clegg D.J., Olson R., Baskin D.G., Myers M.G., et al. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 2003, 52:227-231.
23. Patsalos P.N., Alavijeh M.S., Semba J., Lolin Y.I. A freely moving and behaving rat model for the chronic and simultaneous study of drug pharmacokinetics (blood) and neuropharmacokinetics (cerebrospinal fluid): hematological and biochemical characterization and kinetic evaluation using carbamazepine. J Pharmacol Toxicol Methods 1992, 28:21-28.
24. Pegg C.C., He C., Stroink A.R., Kattner K.A., Wang C.X. Technique for collection of cerebrospinal fluid from the cisterna magna in rat. J Neurosci Methods 2010, 187:8-12.
25. Ryan K.K., Woods S.C., Seeley R.J. Central nervous system mechanisms linking the consumption of palatable high-fat diets to the defense of greater adiposity. Cell Metab 2012, 15:137-149.
26. Sanvitto G.L., Azambuja N.A., Marques M. A technique for collecting cerebrospinal fluid using an intraventricular cannula in rats. Physiol Behav 1987, 41:523-524.
27. Satoh H., Nguyen M.T., Miles P.D., Imamura T., Usui I., Olefsky J.M. Adenovirus-mediated chronic hyper-resistinemia leads to in vivo insulin resistance in normal rats. J Clin Invest 2004, 114:224-231.
28. Shapiro J.S., Stiteler M., Wu G., Price E.A., Simon A.J., Sankaranarayanan S. Cisterna magna cannulated repeated CSF sampling rat model - effects of a gamma-secretase inhibitor on Abeta levels. J Neurosci Methods 2011, 205:36-44.
29. Sharma A.K., Schultze A.E., Cooper D.M., Reams R.Y., Jordan W.H., Snyder P.W. Development of a percutaneous cerebrospinal fluid collection technique in F-344 rats and evaluation of cell counts and total protein concentrations. Toxicol Pathol 2006, 34:393-395.
30. Shen L., Tso P., Woods S.C., Clegg D.J., Barber K.L., Carey K., et al. Brain apolipoprotein E: an important regulator of food intake in rats. Diabetes 2008, 57:2092-2098.
31. Steffens A.B., Scheurink A.J., Porte D., Woods S.C. Penetration of peripheral glucose and insulin into cerebrospinal fluid in rats. Am J Physiol 1988, 255:R200-R204.
32. Stein L.J., Dorsa D.M., Baskin D.G., Figlewicz D.P., Ikeda H., Frankmann S.P., et al. Immunoreactive insulin levels are elevated in the cerebrospinal fluid of genetically obese Zucker rats. Endocrinology 1983, 113:2299-2301.
33. Strubbe J.H., Porte D., Woods S.C. Insulin responses and glucose levels in plasma and cerebrospinal fluid during fasting and refeeding in the rat. Physiol Behav 1988, 44:205-208.
34. Takechi R., Galloway S., Pallebage-Gamarallage M.M., Wellington C.L., Johnsen R.D., Dhaliwal S.S., et al. Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta. Br J Nutr 2010, 103:652-662.
35. Thompson E.J. Cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1995, 59:349-357.
36. Wahlund L.O., Blennow K. Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients. Neurosci Lett 2003, 339:99-102.
37. Wang X., Kimura S., Yazawa T., Endo N. Cerebrospinal fluid sampling by lumbar puncture in rats - repeated measurements of nitric oxide metabolites. J Neurosci Methods 2005, 145:89-95.
38. Westergren I., Johansson B.B. Changes in physiological parameters of rat cerebrospinal fluid during chronic sampling: evaluation of two sampling methods. Brain Res Bull 1991, 27:283-286.
39. Ylitalo P., Heikkinen E.R., Myllyla V.V. Evaluation of sucessive collections of cisternal cerebrospinal fluid in rats, rabbits, and cats. Exp Neurol 1976, 50:330-336.